{"id":31164,"date":"2019-02-12T12:00:00","date_gmt":"2019-02-12T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/"},"modified":"2019-02-12T12:00:00","modified_gmt":"2019-02-12T12:00:00","slug":"perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/","title":{"rendered":"Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1479 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Br\u00fcssel 2018<\/h2>\n<p>Diese kurze Episode ist einem weiteren Feedback eines Patienten zu den vorgeschlagenen L\u00f6sungen gewidmet.<\/p>\n<h3>Podiumsteilnehmende<\/h3>\n<p>Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Patientenvertreter.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1480 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"YouTube-Videoplayer\" src=\"https:\/\/www.youtube.com\/embed\/O-te1OPONl4?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Br\u00fcssel 2018 Diese kurze Episode ist einem weiteren Feedback eines Patienten zu den vorgeschlagenen L\u00f6sungen gewidmet. Podiumsteilnehmende Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Patientenvertreter.<\/p>\n","protected":false},"author":1,"featured_media":31174,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[182],"tags":[183,184,185,186,162],"class_list":["post-31164","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-rhinologie","tag-debatten","tag-rhinology-future-debates","tag-biologika","tag-gesundheitsfachkrafte"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Br\u00fcssel 2018 Diese kurze Episode ist einem weiteren Feedback eines Patienten zu den vorgeschlagenen L\u00f6sungen gewidmet. Podiumsteilnehmende Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Patientenvertreter.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\\\/\",\"name\":\"Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_21.png\",\"datePublished\":\"2019-02-12T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_21.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202018_21.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/waehlen-sie-ihren-weg\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/de\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/","og_locale":"de_DE","og_type":"article","og_title":"Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht","og_description":"Rhinology Future Debates Br\u00fcssel 2018 Diese kurze Episode ist einem weiteren Feedback eines Patienten zu den vorgeschlagenen L\u00f6sungen gewidmet. Podiumsteilnehmende Catherine Lucet, Claus Bachert, Joaquim Mullol, Peter Hellings, Charles Pilette, Renaud Louis, Philippe Rombaux, Patientenvertreter.","og_url":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/","url":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/","name":"Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_21.png","datePublished":"2019-02-12T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_21.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202018_21.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/de\/news\/perspektiven-zur-einfuehrung-biologischer-therapien-aus-patientensicht\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.euforea.org\/de\/waehlen-sie-ihren-weg\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/de\/news\/"},{"@type":"ListItem","position":3,"name":"Perspektiven zur Einf\u00fchrung biologischer Therapien aus Patientensicht"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/de\/#website","url":"https:\/\/www.euforea.org\/de\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/de\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/de\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.euforea.org\/de\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/de\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/news\/31164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/comments?post=31164"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/news\/31164\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/media\/31174"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/media?parent=31164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/categories?post=31164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/de\/wp-json\/wp\/v2\/tags?post=31164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}